Analysts Have Conflicting Sentiments on These Healthcare Companies: Fulgent Genetics (FLGT), Cigna (CI) and PROCEPT BioRobotics (PRCT)
TipRanks58minutes ago
Fulgent Genetics Analyst Ratings
BenzingaMar 6 22:31
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
TipRanksMar 6 20:36
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating
MT NewswiresMar 1 02:00
UBS Initiates Coverage On Fulgent Genetics With Neutral Rating, Announces Price Target of $35
BenzingaDec 7, 2023 19:06
Fulgent Genetics Analyst Ratings
BenzingaDec 7, 2023 19:04
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $28
BenzingaOct 17, 2023 01:25
Fulgent Genetics Analyst Ratings
BenzingaOct 17, 2023 01:24
Piper Sandler Sticks to Their Hold Rating for Fulgent Genetics (FLGT)
TipRanksMay 8, 2023 20:41
Credit Suisse Lowers Fulgent Genetics' Price Target to $45 From $50 After Mixed Q4 Results, Keeps Outperform Rating
MT NewswiresMar 2, 2023 22:51
Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to $45
BenzingaMar 2, 2023 19:45
Fulgent Genetics (FLGT) Gets a Buy From Raymond James
TipRanksMar 1, 2023 19:11
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsDec 8, 2022 18:16
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsNov 18, 2022 20:31
Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45
Benzinga Real-time NewsNov 18, 2022 20:31
Credit Suisse Adjusts Fulgent Genetics' Price Target to $50 From $65, Keeps Outperform Rating
MT NewswiresNov 15, 2022 00:00
Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to $50
Benzinga Real-time NewsNov 14, 2022 20:30
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsNov 14, 2022 19:57
No Data
No Data